長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4582】シンバイオ製薬

【4582】シンバイオ製薬
医薬品販売。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 大幸薬品 カイノス


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2024.12 2024/10/31 Q3予 2,623 → 0.0% -28.0% -3,702 → 0.0% -30.5% -3,524 → 0.0% -22.9% -3,628 → 0.0% -26.4%
2024.12 2024/08/01 Q2予 2,623 → 0.0% -28.0% -3,702 → 0.0% -30.5% -3,524 → 0.0% -22.9% -3,628 → 0.0% -26.4%
2024.12 2024/05/07 Q1予 2,623 ↓ -28.0% -28.0% -3,702 ↓ -30.5% -30.5% -3,524 ↓ -22.9% -22.9% -3,628 ↓ -26.4% -26.4%
2024.12 2024/02/08 当初予 3,641 - - - -2,837 - - - -2,867 - - - -2,870 - - -
2023.12 2024/02/08 実 5,589 ↓ -0.2% -20.2% -811 ↓ -19.3% -145.0% -736 ↓ -34.1% -109.7% -1,962 ↓ -52.0% -430.3%
2023.12 2023/11/14 Q3予 5,603 ↓ -13.5% -20.0% -680 ↓ -105.4% -105.4% -549 ↓ -150.7% -56.4% -1,291 ↓ -248.9% -248.9%
2023.12 2023/08/03 Q2予 6,477 ↓ -7.5% -7.5% -331 → 0.0% 0.0% -219 ↑ +37.6% +37.6% -370 → 0.0% 0.0%
2023.12 2023/04/27 Q1予 7,000 → 0.0% 0.0% -331 → 0.0% 0.0% -351 → 0.0% 0.0% -370 → 0.0% 0.0%
2023.12 2023/02/09 当初予 7,000 - - - -331 - - - -351 - - - -370 - - -
2022.12 2023/02/09 実 10,008 ↑ +0.0% -9.0% 1,963 ↓ -1.8% +10.9% 1,999 ↓ -13.1% +14.2% 1,179 ↓ -28.5% -20.3%
2022.12 2022/11/08 Q3予 10,003 → 0.0% -9.0% 2,000 ↑ +13.0% +13.0% 2,300 ↑ +31.4% +31.4% 1,650 ↑ +11.5% +11.5%
2022.12 2022/08/04 Q2予 10,003 ↓ -9.0% -9.0% 1,770 → 0.0% 0.0% 1,750 ↓ -1.1% 0.0% 1,480 → 0.0% 0.0%
2022.12 2022/05/11 Q1予 10,992 → 0.0% 0.0% 1,770 → 0.0% 0.0% 1,770 ↑ +1.1% +1.1% 1,480 → 0.0% 0.0%
2022.12 2022/02/10 当初予 10,992 - - - 1,770 - - - 1,750 - - - 1,480 - - -
2021.12 2022/02/10 実 8,256 ↓ -9.8% -9.8% 1,016 ↓ -25.3% -25.3% 1,001 ↓ -25.9% -25.9% 2,032 ↑ +76.8% +76.8%
2021.12 2021/11/11 Q3予 9,151 → 0.0% 0.0% 1,361 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,149 → 0.0% 0.0%
2021.12 2021/08/04 Q2予 9,151 → 0.0% 0.0% 1,361 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,149 → 0.0% 0.0%
2021.12 2021/05/13 Q1予 9,151 → 0.0% 0.0% 1,361 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,149 → 0.0% 0.0%
2021.12 2021/02/04 当初予 9,151 - - - 1,361 - - - 1,350 - - - 1,149 - - -
2020.12 2021/02/04 実 2,987 ↓ -1.8% -12.3% -4,506 ↑ +1.9% +11.5% -4,615 ↑ +0.9% +10.1% -4,090 ↓ -7.7% +14.8%
2020.12 2020/11/10 Q3予 3,043 ↓ -10.6% -10.6% -4,592 ↑ +9.8% +9.8% -4,656 ↑ +9.3% +9.3% -3,796 ↑ +21.0% +21.0%
2020.12 2020/08/05 Q2予 3,404 → 0.0% 0.0% -5,090 → 0.0% 0.0% -5,134 → 0.0% 0.0% -4,803 → 0.0% 0.0%
2020.12 2020/05/12 Q1予 3,404 → 0.0% 0.0% -5,090 → 0.0% 0.0% -5,134 → 0.0% 0.0% -4,803 → 0.0% 0.0%
2020.12 2020/02/06 当初予 3,404 - - - -5,090 - - - -5,134 - - - -4,803 - - -
2019.12 2020/02/06 実 2,837 ↓ -8.2% -36.5% -4,301 ↓ -13.8% -19.9% -4,376 ↓ -13.5% -21.2% -4,376 ↓ -13.4% -21.0%
2019.12 2019/11/08 Q3予 3,092 → 0.0% -30.8% -3,780 → 0.0% -5.4% -3,856 → 0.0% -6.8% -3,859 → 0.0% -6.7%
2019.12 2019/08/07 Q2予 3,092 ↓ -30.8% -30.8% -3,780 ↓ -5.4% -5.4% -3,856 ↓ -6.8% -6.8% -3,859 ↓ -6.7% -6.7%
2019.12 2019/05/14 Q1予 4,465 → 0.0% 0.0% -3,587 → 0.0% 0.0% -3,612 → 0.0% 0.0% -3,616 → 0.0% 0.0%
2019.12 2019/02/07 当初予 4,465 - - - -3,587 - - - -3,612 - - - -3,616 - - -
2018.12 2019/02/07 実 3,835 ↓ -8.7% -8.7% -2,656 ↑ +10.9% +10.9% -2,748 ↑ +9.7% +9.7% -2,752 ↑ +9.9% +9.9%
2018.12 2018/11/09 Q3予 4,201 → 0.0% 0.0% -2,981 → 0.0% 0.0% -3,044 → 0.0% 0.0% -3,056 → 0.0% 0.0%
2018.12 2018/08/07 Q2予 4,201 → 0.0% 0.0% -2,981 → 0.0% 0.0% -3,044 → 0.0% 0.0% -3,056 → 0.0% 0.0%
2018.12 2018/05/10 Q1予 4,201 → 0.0% 0.0% - - - - -3,044 → 0.0% 0.0% -3,056 → 0.0% 0.0%
2018.12 2018/02/07 当初予 4,201 - - - -2,981 - - - -3,044 - - - -3,056 - - -
2017.12 2018/02/07 実 3,444 ↓ -3.9% +18.6% -3,947 ↓ -0.4% -21.9% -3,976 ↑ +0.8% -20.4% -3,977 ↑ +0.8% -20.3%
2017.12 2017/11/10 Q3予 3,583 ↑ +23.4% +23.4% -3,932 ↓ -21.4% -21.4% -4,009 ↓ -21.4% -21.4% -4,009 ↓ -21.3% -21.3%
2017.12 2017/08/03 Q2予 2,903 → 0.0% 0.0% -3,238 → 0.0% 0.0% -3,303 → 0.0% 0.0% -3,306 → 0.0% 0.0%
2017.12 2017/05/11 Q1予 2,903 → 0.0% 0.0% -3,238 → 0.0% 0.0% -3,303 → 0.0% 0.0% -3,306 → 0.0% 0.0%
2017.12 2017/02/09 当初予 2,903 - - - -3,238 - - - -3,303 - - - -3,306 - - -
2016.12 2017/02/09 実 2,368 ↑ +1.2% +1.2% -2,127 ↑ +23.4% +23.4% -2,316 ↑ +17.6% +17.6% -2,313 ↑ +17.8% +17.8%
2016.12 2016/11/11 Q3予 2,339 → 0.0% 0.0% -2,778 → 0.0% 0.0% -2,811 → 0.0% 0.0% -2,815 → 0.0% 0.0%
2016.12 2016/08/04 Q2予 2,339 → 0.0% 0.0% -2,778 → 0.0% 0.0% -2,811 → 0.0% 0.0% -2,815 → 0.0% 0.0%
2016.12 2016/05/10 Q1予 2,339 → 0.0% 0.0% -2,778 → 0.0% 0.0% -2,811 → 0.0% 0.0% -2,815 → 0.0% 0.0%
2016.12 2016/02/10 当初予 2,339 - - - -2,778 - - - -2,811 - - - -2,815 - - -
2015.12 2016/02/10 実 1,933 ↑ +3.4% +3.4% -2,551 ↓ -4.0% -4.0% -2,630 ↓ -6.0% -6.0% -2,632 ↓ -5.9% -5.9%
2015.12 2015/11/06 Q3予 1,870 → 0.0% 0.0% -2,452 → 0.0% 0.0% -2,481 → 0.0% 0.0% -2,485 → 0.0% 0.0%
2015.12 2015/08/05 Q2予 1,870 → 0.0% 0.0% -2,452 → 0.0% 0.0% -2,481 → 0.0% 0.0% -2,485 → 0.0% 0.0%
2015.12 2015/05/07 Q1予 1,870 → 0.0% 0.0% -2,452 - - - -2,481 → 0.0% 0.0% -2,485 → 0.0% 0.0%
2015.12 2015/02/10 当初予 1,870 - - - - - - - -2,481 - - - -2,485 - - -
2014.12 2015/02/10 実 - - - - - - - - - - - - - - - -
2014.12 2014/11/07 Q3予 1,785 → 0.0% 0.0% -1,654 → 0.0% 0.0% -1,650 → 0.0% 0.0% -1,654 → 0.0% 0.0%
2014.12 2014/08/06 Q2予 1,785 → 0.0% 0.0% -1,654 → 0.0% 0.0% -1,650 → 0.0% 0.0% -1,654 → 0.0% 0.0%
2014.12 2014/05/08 Q1予 1,785 → 0.0% 0.0% -1,654 → 0.0% 0.0% -1,650 → 0.0% 0.0% -1,654 → 0.0% 0.0%
2014.12 2014/02/12 当初予 1,785 - - - -1,654 - - - -1,650 - - - -1,654 - - -
2013.12 2014/02/12 実 1,532 - - - -1,680 - - - -1,601 - - - -1,605 - - -
シェア ツイート
ページトップへ戻る